September 10, 2025OncoTargets and TherapyOpen Access

Upregulation of SHIP2 Participates in the Development of Breast Cancer via Promoting Wnt/β-Catenin Signaling Retraction

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retraction of findings reveals SHIP2's influence on Wnt/beta-Catenin signaling in breast cancer.

Increased levels of SHIP2 are linked to breast cancer progression, highlighting its potential as a target for treatment.
The study indicated that SHIP2 enhances Wnt/beta-catenin signaling, which is crucial for cancer cell growth and survival.
This paper was retracted due to concerns about the validity of the data supporting the role of SHIP2 in breast cancer.
The findings underscore the importance of rigorous scientific review in cancer research to ensure accurate conclusions.

Zhou et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark